You are here » Home » Companies » Company Overview » Transgene Biotek Ltd

Transgene Biotek Ltd.

BSE: 526139 Sector: Health care
NSE: N.A. ISIN Code: INE773D01018
BSE 00:00 | 20 Oct 4.07 -0.05
(-1.21%)
OPEN

4.20

HIGH

4.20

LOW

3.92

NSE 05:30 | 01 Jan Transgene Biotek Ltd
OPEN 4.20
PREVIOUS CLOSE 4.12
VOLUME 7892
52-Week high 6.85
52-Week low 2.05
P/E
Mkt Cap.(Rs cr) 31
Buy Price 3.92
Buy Qty 1671.00
Sell Price 4.07
Sell Qty 63.00
OPEN 4.20
CLOSE 4.12
VOLUME 7892
52-Week high 6.85
52-Week low 2.05
P/E
Mkt Cap.(Rs cr) 31
Buy Price 3.92
Buy Qty 1671.00
Sell Price 4.07
Sell Qty 63.00

Transgene Biotek Ltd. (TRANSGENEBIOTEK) - Company History

Transgene Biotek was incorporated as a private limited company in Mar.'90 and was converted into a public limited company in Nov.'90. The company is engaged in the research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for the qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively. Transgene Biotek's products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility at a cost of Rs.30 crore at the Anrich Industrial Area,Bollaram. TBL is working of four new plants:Oral deliver of proteins and peptides:DNA vaccines:fusion proteins and bio therapeutics. The new project is being funded by way of preferential offer to Batterymarch Financial management USA and other financial institutions.

.